EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Clinical advancements in mRNA vaccines against viral infections

Munazza Fatima, Pil-Gu Park, Kee-Jong Hong

Clinical Immunology · 2025-02 · 271 · 110424

DOI: 10.1016/j.clim.2024.110424 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Immunology, 2025-02. Verfasst von Munazza Fatima und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Gachon University College of Medicine, Incheon, Republic of Korea; Lee Gil Ya Cancer and Diabetes Institute, Gachon Unive…. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, SARS-CoV-2, Vaccines, Synthetic. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 123 Literaturangaben. Gefördert von: Ministry of Food and Drug Safety, Gachon University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the last decade, mRNA vaccines development has shown significant advancement, particularly during the COVID-19 pandemic. This comprehensive review examines the efficacy of pivotal vaccines against emerging COVID-19 variants and strategies for enhancing vaccine effectiveness. It also explores the versatility of mRNA technology in addressing other infectious diseases such as influenza, respiratory syncytial virus, HIV, cytomegalovirus, Ebola, Zika, Rabies, and Nipah viruses. The analysis includes safety and clinical progress of mRNA vaccines and evaluates their potential in combination vaccine strategies. Additionally, it addresses challenges related to delivery and scalability while highlighting opportunities for future advancements in the field. Recent advances in mRNA optimization, biomaterial-based delivery and thermostable designs offer promising solutions. It is essential to gain insights into the evolving landscape of mRNA vaccine technology to maximize its vital role in addressing diverse viral threats, advancing vaccinology and enhancing public health preparedness for future pandemic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesSARS-CoV-2Vaccines, SyntheticVirus DiseasesViral VaccinesHumansmRNA VaccinesVaccine Development

Stichwörter der Autor:innen

COVID-19Clinical trialsViral infectionsmRNA vaccines

Substanzen

COVID-19 VaccinesVaccines, SyntheticmRNA VaccinesViral Vaccines

Autor:innen und Institutionen

  • Department of Microbiology, Gachon University College of Medicine, Incheon, Republic of Korea; Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Republic of Korea.
  • Department of Microbiology, Gachon University College of Medicine, Incheon, Republic of Korea; Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Republic of Korea; Department of Health Sciences and T…

Förderung

  • Ministry of Food and Drug Safety
  • Gachon University

Zitieren

APA

Fatima, M., Park, P. G., & Hong, K. J. (2025). Clinical advancements in mRNA vaccines against viral infections. Clinical Immunology, 271, 110424. https://doi.org/10.1016/j.clim.2024.110424

Vancouver

Fatima M, Park PG, Hong KJ. Clinical advancements in mRNA vaccines against viral infections. Clinical Immunology. 2025;271:110424. doi:10.1016/j.clim.2024.110424

BibTeX
@article{Fatima2025,
  author = {Fatima, Munazza and Park, Pil-Gu and Hong, Kee-Jong},
  title = {Clinical advancements in mRNA vaccines against viral infections},
  journal = {Clinical Immunology},
  year = {2025},
  volume = {271},
  pages = {110424},
  doi = {10.1016/j.clim.2024.110424}
}
Kostenlos starten →